Every autumn I meet candidates who have spent months preparing for investment banking without being able to say what the investment banking division actually does. They know the hours are long and the pay is high. Ask them what an analyst produces on a Tuesday, or why IBD sits in a different building from the trading floor, and the answer dissolves. Interviewers notice, because the first thing a weak candidate confuses is IBD with the markets business.
I spent fifteen years inside the division, first in M&A at BNP Paribas in Paris and London, then as an Executive Director in TMT at Nomura in Hong Kong. This is the map I wish someone had drawn for me before my first interview.
One sentence, then the detail
IBD advises companies and governments on the biggest financial decisions they make: buying or selling a business, raising equity, raising debt. The client is the company. The product is advice and execution, and the bank earns a fee when the transaction completes. That is the whole business in three lines, and every job in the division is a variation on it.
The four products that matter
- M&A. Advising a company on buying another, selling itself or divesting a unit. Analysts build valuation models, run the process, draft the documents that move ownership. It is the most execution-dense seat and the one buy-side recruiters treat as a proxy for training.
- ECM, equity capital markets. Raising equity: IPOs, follow-ons, convertibles, block trades. The work lives on pricing, investor demand and market windows. Less modelling, more markets feel, and the hours track the calendar rather than the deal.
- DCM, debt capital markets. Bond issuance for corporates, banks and sovereigns. High volume, fast cycles, real client contact early. The trade-off is that a DCM analyst can go a year without building a full operating model.
- Leveraged finance. Structuring debt for private equity buyouts and sub-investment-grade companies. Credit analysis plus real modelling plus sponsor clients. In banks where LevFin runs the model, it is one of the best trained seats in the building.
Restructuring sits alongside these as the countercyclical craft, busiest when everything else is quiet. And cutting across all of it are the coverage teams, organised by industry rather than product, which own the client relationships. If you are deciding between a sector seat and a product seat, I have written a separate piece on how to choose between industry and product groups.
Why IBD is not the markets floor
The confusion is understandable because both sit inside something called an investment bank. But global markets, the sales and trading business, serves a different client with a different product. Markets serves investors: funds, insurers, asset managers who buy and sell securities every day. IBD serves issuers: the companies those securities are claims on. Markets earns spread and commission continuously. IBD earns fees in lumps when deals close.
The daily texture follows from that. A trading floor lives minute to minute, positions marked all day, done by early evening. An IBD floor lives deal to deal, quiet mornings and brutal nights, weekends lost to a signing. Different skills, different personalities, different careers. The regulatory wall between the two, since the division holds inside information on live transactions, is also why the buildings, systems and even lifts are often separate.
For recruiting, this distinction is not trivia. Applications are separate, interviews are different, and the fastest way to fail an IBD interview is to give a markets answer: talking about your passion for following stocks when the job is advising companies. If a bank asks why IBD and not sales and trading, they are testing whether you understand what you applied for.
Where the other divisions fit
A full-service bank also runs equity research, asset management, wealth or private banking, and a transaction banking business moving payments and trade finance. Each is a real career. None of them is IBD, and a CV that scatters applications across all of them tells every screener the same thing: this person has not chosen. Banks can live with ambition. They struggle with vagueness.
What an analyst actually produces
Back to that Tuesday. An IBD analyst spends it building and updating valuation models, drafting pitch and process materials, maintaining buyer lists and data rooms, and turning comments from the deal team above them: an associate checking the work, a VP running the workstream, a director or MD owning the client. The pyramid is the same in every group, and it explains the hours, because the analyst is the production layer and production is pulled by deadlines the client sets. It also explains the training: 2 years of that volume builds a technical base almost no other graduate job can match, which is why the exit market prices the seat the way it does.
What this means for your application
- Pick the division first, the bank second. The gap between IBD and markets is wider than the gap between two banks. Your story, your preparation and your technicals all fork at that first choice.
- Learn the fee logic. If you can explain how a bank earns from an IPO versus a bond versus a merger, you already sound more commercial than most applicants.
- Match the product to your evidence. A markets-heavy CV pointed at M&A needs a bridge sentence. Build it before the interviewer asks.
And when you choose between platforms, the division question compounds with the firm question. My honest comparison of bulge brackets, elite boutiques and mid-market firms covers that half of the decision.
FAQ
Is IBD the same as investment banking?
Colloquially yes, technically no. Investment bank describes the whole institution; IBD is the advisory division inside it. When candidates say they want to be investment bankers, they almost always mean IBD, and interviewers will hold them to that meaning.
Which product is best for exits?
M&A and leveraged finance map most directly to private equity because they build modelling and deal reps. Capital markets seats are genuinely good jobs with narrower buy-side maps. But the busiest team at a decent bank beats a sleepy team at a famous one, whatever the product.
Can I switch from markets to IBD later?
It happens, but it is a real move, not a shuffle. Internal transfers need a sponsor and usually a timing window early in your career. It is far cheaper to choose correctly at the application stage than to engineer a switch at 25.
If you are still deciding which seat fits your profile, or your applications are pointed at the wrong ones, that is precisely what the IBD Recruiting Review diagnoses in an hour.
Book the 60-min IBD ReviewView Full Cycle
Former Executive Director in TMT Investment Banking at Nomura and M&A banker at BNP Paribas. Top-rated Head Mentor on Wall Street Oasis with 300+ sessions. About
